Saint-Gilles Pharma: what changed
What changed
Saint-Gilles Pharma
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€10,615
2024 · €18,303-€7,688
Equity
€252,269
2024 · €241,654+€10,615
Cash
€273,760
2024 · €312,516-€38,756
Balance sheet total
€556,225
2024 · €637,987-€81,763
Largest movements
Assets
- Intangible fixed assets -€51,401
down €51,401 (-25.0%), from €205,603 to €154,202
- Cash -€38,756
down €38,756 (-12.4%), from €312,516 to €273,760
mainly Debts after one year (-€77,642) and Investment in fixed assets (net) (-€11,021)
Equity and liabilities
- Debts after one year -€77,642
down €77,642 (-31.9%), from €243,104 to €165,463
- Reserves +€10,615
up €10,615 (+4.5%), from €235,454 to €246,069
- Other debts -€7,861
down €7,861 (-34.6%), from €22,751 to €14,891
- Trade debts -€6,407
down €6,407 (-14.4%), from €44,618 to €38,210
Income statement
- Gross operating margin -€8,713
down €8,713 (-10.2%), from €85,745 to €77,032
- Depreciation +€2,369
up €2,369 (+4.4%), from €54,376 to €56,745
- Staff costs -€2,159
no longer reported in 2025 (was €2,159)
- Taxes -€1,942
down €1,942 (-33.4%), from €5,816 to €3,874
- Financial income -€1,163
down €1,163 (-48.3%), from €2,408 to €1,244
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€18,303
Gross operating margin
-€8,713
Staff costs
+€2,159
Depreciation
-€2,369
Other operating charges
-€253
Other operating items
-€430
Financial income
-€1,163
Financial charges
+€1,139
Taxes
+€1,942
Result 2025
€10,615
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€48,680
Investment
-€11,021
Financing
-€76,416
Cash 2024
€312,516
From operations (derived)
+€48,680
Net result for the year
+€10,615
Depreciation
+€56,745
Stocks and contracts
-€3,894
Receivables within one year
+€2,615
Deferred charges and accrued income
-€1,439
Trade debts
-€6,407
Tax, wage and social debts
-€1,694
Other debts
-€7,861
Investment (derived)
-€11,021
Investment in fixed assets (net)
-€11,021
Financing
-€76,416
Debts after one year
-€77,642
Current portion of long-term debt
+€1,226
Cash 2025
€273,760
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €637,987 | €556,225 | -€81,763 | -12.8% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €222,994 | €177,270 | -€45,724 | -20.5% |
| Intangible fixed assets | 21 | €205,603 | €154,202 | -€51,401 | -25.0% |
| Tangible fixed assets | 22/27 | €8,734 | €14,411 | +€5,677 | +65.0% |
| Furniture and vehicles | 24 | €3,479 | €3,987 | +€508 | +14.6% |
| Other tangible fixed assets | 26 | €5,255 | €10,424 | +€5,169 | +98.4% |
| Assets under construction and advance payments | 27 | €0 | €0 | = | |
| Financial fixed assets | 28 | €8,657 | €8,657 | = | 0.0% |
| Current assets | 29/58 | €414,993 | €378,954 | -€36,039 | -8.7% |
| Stocks and contracts in progress | 3 | €60,020 | €63,914 | +€3,894 | +6.5% |
| Stocks | 30/36 | €60,020 | €63,914 | +€3,894 | +6.5% |
| Amounts receivable within one year | 40/41 | €40,020 | €37,405 | -€2,615 | -6.5% |
| Trade receivables | 40 | €39,250 | €35,297 | -€3,953 | -10.1% |
| Other amounts receivable | 41 | €770 | €2,108 | +€1,338 | +174% |
| Cash at bank and in hand | 54/58 | €312,516 | €273,760 | -€38,756 | -12.4% |
| Deferred charges and accrued income | 490/1 | €2,437 | €3,876 | +€1,439 | +59.1% |
| Total equity and liabilities | 10/49 | €637,987 | €556,225 | -€81,763 | -12.8% |
| Equity | 10/15 | €241,654 | €252,269 | +€10,615 | +4.4% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €235,454 | €246,069 | +€10,615 | +4.5% |
| Distributable reserves | 133 | €235,454 | €246,069 | +€10,615 | +4.5% |
| Amounts payable | 17/49 | €396,333 | €303,956 | -€92,377 | -23.3% |
| Amounts payable after more than one year | 17 | €243,104 | €165,463 | -€77,642 | -31.9% |
| Financial debts | 170/4 | €243,104 | €165,463 | -€77,642 | -31.9% |
| Amounts payable within one year | 42/48 | €153,229 | €138,493 | -€14,736 | -9.6% |
| Current portion of amounts payable after more than one year | 42 | €82,834 | €84,060 | +€1,226 | +1.5% |
| Trade debts | 44 | €44,618 | €38,210 | -€6,407 | -14.4% |
| Suppliers | 440/4 | €44,618 | €38,210 | -€6,407 | -14.4% |
| Taxes, remuneration and social security | 45 | €3,025 | €1,332 | -€1,694 | -56.0% |
| Taxes | 450/3 | €3,025 | €1,332 | -€1,694 | -56.0% |
| Other amounts payable | 47/48 | €22,751 | €14,891 | -€7,861 | -34.6% |
| Remuneration, social security and pensions | 62 | €2,159 | - | -€2,159 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €54,376 | €56,745 | +€2,369 | +4.4% |
| Other operating charges | 640/8 | €836 | €1,089 | +€253 | +30.2% |
| Non-recurring operating charges | 66A | - | €430 | +€430 | |
| Gross operating margin | 9900 | €85,745 | €77,032 | -€8,713 | -10.2% |
| Operating profit (loss) | 9901 | €28,374 | €18,769 | -€9,605 | -33.9% |
| Financial income | 75/76B | €2,408 | €1,244 | -€1,163 | -48.3% |
| Recurring financial income | 75 | €2,408 | €1,244 | -€1,163 | -48.3% |
| Financial charges | 65/66B | €6,664 | €5,525 | -€1,139 | -17.1% |
| Recurring financial charges | 65 | €6,664 | €5,525 | -€1,139 | -17.1% |
| Profit (loss) for the period before taxes | 9903 | €24,118 | €14,489 | -€9,630 | -39.9% |
| Income taxes | 67/77 | €5,816 | €3,874 | -€1,942 | -33.4% |
| Profit (loss) for the period | 9904 | €18,303 | €10,615 | -€7,688 | -42.0% |
| Profit (loss) for the period to be appropriated | 9905 | €18,303 | €10,615 | -€7,688 | -42.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.